Financial Toxicity: Inequities and Impact on Cardiovascular Disease
Healthcare costs are ever increasing, with impacts across all socioeconomic backgrounds. As a result, financial strain and financial toxicity are a consequences of rising healthcare costs and economic variations, with significant negative impacts on cardiovascular disease. This review explores financial toxicity and the interplay of net worth, financial mobility, and social determinants of health in cardiovascular disease while also addressing the role of advocacy and policy in public health. Given the significant multidimensional aspects of financial toxicity, understanding its impact on cardiovascular disease is crucial to improving outcomes on a population-wide scale.
Authors
- Laurence S. Sperling (ORCID: https://orcid.org/0000-0001-9417-6370)
- Salim S. Virani (ORCID: https://orcid.org/0000-0001-9541-6954)
- Kevin Benavente (ORCID: https://orcid.org/0000-0003-4219-7780)
- Chayakrit Krittanawong (ORCID: https://orcid.org/0000-0001-7953-335X)
- Charlotte Park
- Carl J. Lavie (ORCID: https://orcid.org/0000-0003-3906-1911)
- Yochai Birnbaum (ORCID: https://orcid.org/0000-0001-7653-6328)
- Dina Abushanab (ORCID: https://orcid.org/0000-0002-4162-8617)
- Clarke Morihara (ORCID: https://orcid.org/0009-0006-6802-2726)
- Hafeez Ul Hassan Virk (ORCID: https://orcid.org/0000-0002-9835-942X)
Institutions
- University of Hawaiʻi at Mānoa (US)
- Aga Khan University (PK)
- Emory University (US)
- Baylor College of Medicine (US)
- University Hospitals of Cleveland (US)
- Ochsner Medical Center (US)
- University Hospitals Cleveland Medical Center (US)
- Hamad Medical Corporation (QA)
- University of Delaware (US)
Publication Details
- Journal
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2026-06-25
- DOI
- https://doi.org/10.1161/atvbaha.125.324015
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00